Vaishali Pharma Quarterly Results

Pros & Cons

POSITIVES

Revenue growth shows a consistent upward trend, indicating strong demand in the manufacturing sector.
Gross margins improved due to better cost management and operational efficiencies.
Net profit margins have increased, reflecting effective expense management and revenue generation.

NEGATIVES

High raw material costs have pressured profitability, impacting the bottom line.
Debt levels have risen, raising concerns over financial stability and repayment capacity.
Market competition intensified, leading to potential pricing pressures and reduced market share.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	12.57	27.89	32.40	18.08	20.79	27.91	32.25	23.75
Expenses	9.91	24.94	39.18	15.74	18.37	26.55	38.29	22.38
Operating Profit	2.66	2.95	-6.78	2.34	2.42	1.37	-6.04	1.37
Other Income	0.30	0.47	0.91	0.42	0.71	1.07	1	0.84
Interest	0.47	0.43	0.40	0.38	0.38	0.38	0.44	0.33
Depreciation	0.12	0.12	0.14	0.12	0.12	0.12	0.12	0.14
Profit Before Tax	2.36	2.86	-6.42	2.27	2.63	1.93	-5.60	1.74
Tax	0.66	0.75	-1.73	0.57	0.66	0.48	-1.31	0.46
Net Profit	1.70	2.11	-4.68	1.70	1.97	1.44	-4.29	1.28
Eps in Rs	1.61	1.99	-4.37	1.48	1.51	0.98	-3.17	0.10